Note:
This awardee has received supplemental funding. This award detail page includes information about both the original award and supplemental awards.
Award Information
Description of original award (Fiscal Year 2020, $2,000,000)
The Harold Rogers Prescription Drug Monitoring Program (PDMP) enhances the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized agency.
PDMPs help state and local governments to detect and prevent the diversion and abuse of pharmaceutically controlled substances such as opioids and other prescription drugs. The Harold Rogers PDMP strengthens states and territories ability to plan, implement, or enhance PDMPs by accommodating local decision-making based on state laws and preferences, while encouraging the replication of promising practices. In addition to supporting the implementation and enhancement of PDMPs, the program can support the Administrations priority of tracking prescribing across providers and states through the integration of PDMPs and Electronic Health Records (EHRs) and Health Information Exchanges (HIEs) which are essential to promoting safe and responsible prescribing, while also assuring appropriate pain care.
The applicant will improve clinical decisionmaking and prevent abuse and diversion of controlled substances by integrating at least 700 providers of substance abuse treatment and healthcare services to clients at risk of addiction and overdose. It will improve decisionmaking regarding diversion of substance-addicted (SA) offenders to treatment by drug courts and treatment engagement of SA inmates through an offender reentry program by integrating at least 355 of Puerto Ricos (PRs) authorized representatives of the corrections, court administration, police, and forensic science agencies to the PDMP. The applicant will also address public policy and legislative changes to enable PR PDMP operational enhancements, and it will determine the incidence and prevalence of certain medical and nonmedical uses of controlled drugs in PR at state, regional, and municipal levels by carrying out epidemiological analyses of the PDMP data.
CA/NCF